Viewing Study NCT04784767


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2025-12-25 @ 10:38 PM
Study NCT ID: NCT04784767
Status: COMPLETED
Last Update Posted: 2025-06-17
First Post: 2021-03-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19
Sponsor: U.S. Army Medical Research and Development Command
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module